Jose-Carlos (JC) Gutiérrez-Ramos is CEO of Cogen Therapeutics and brings over 20 years of drug discovery and development experience from leading global biopharmaceutical companies. Previously, he was the CEO and president of Synlogic, Inc. where he led the company through raising more than $200MM in private and public financing rounds, and had the company listed on NASDAQ. He also led the transformation of an academic spin-out into a fully integrated discovery and development organization with a team of 70 people.
JC also served as group senior vice president and global head of the BioTherapeutics Research at Pfizer where he was responsible for more than 25 novel programs across the full spectrum of clinical development, re-launched efforts in rare disease discovery and development and founded the Centers for Therapeutic Innovation. Before that, he was senior vice president and head of the Immuno-inflammation Center for Drug Discovery (iiCEDD) at GSK, where he founded entrepreneurial units, such as Epinova and Tempero, focused on translating novel areas of science into therapeutics.
He began his career in the drug industry at Millennium Pharmaceuticals serving as vice president of inflammation drug discovery. During his academic career he was part of the faculty at the genetics department of Harvard Medical School and the Basel Institute for Immunology in Switzerland.
Jose-Carlos holds a Ph.D. in immunochemistry from the Autonoma University in Madrid, Spain.